With the Oregon Ducks' 2026 team less than 90 days away from the start of their new season, the expectations surrounding the team are as high as ever. The Ducks and coach Dan Lanning will be expected ...

Should the Boston Celtics try to take former Arkansas Razorbacks forward Trevon Brazile in the 2026 NNA Draft? A 6-foot-10 forward projected to be picked up by an NBA team in the first third of the ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

Forward Predict runs proposed network changes against a network digital twin and models the impact before any change touches the live environment. Forward (formerly Forward Networks) has been building ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an unusually ambitious goal: building AI systems capable of improving themselves ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

A London-based AI startup set up just months ago, which believes it’s pursuing the fastest path to surpassing human intelligence, has today come out of stealth, having raised over $650m at a $4.65bn ...

As we approach the NBA offseason, Brad Stevens is expected to be busy reshaping the Boston Celtics roster. Joe Mazzulla's team squandered a 3-1 lead over the Philadelphia 76ers during the opening ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...